科华生物
(002022)
| 流通市值：30.86亿 | | | 总市值：30.86亿 |
| 流通股本：5.14亿 | | | 总股本：5.14亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 803,919,372.94 | 857,927,277.45 | 874,987,252.95 | 817,502,589.16 |
| 交易性金融资产 | 305,656.8 | 60,362,058.87 | 299,624.1 | 274,487.85 |
| 应收票据及应收账款 | 642,835,942.55 | 604,433,643.8 | 751,631,342.56 | 832,642,233.07 |
| 其中：应收票据 | 7,885,496.86 | 7,694,705.55 | 6,174,026.59 | 11,236,897.68 |
| 应收账款 | 634,950,445.69 | 596,738,938.25 | 745,457,315.97 | 821,405,335.39 |
| 应收款项融资 | 6,866,583.49 | 2,676,863.49 | 6,381,784.19 | 12,837,294.94 |
| 预付款项 | 111,025,539.98 | 95,671,307.93 | 100,238,173.58 | 102,249,542.99 |
| 其他应收款合计 | 34,323,408.41 | 28,210,917.39 | 32,739,975.22 | 13,425,557.46 |
| 存货 | 635,697,431.92 | 643,513,381.91 | 832,418,619.38 | 843,870,623.24 |
| 其他流动资产 | 102,142,153.4 | 114,362,499.61 | 117,825,503.77 | 116,525,349.79 |
| 流动资产合计 | 2,337,116,089.49 | 2,407,157,950.45 | 2,716,522,275.75 | 2,739,327,678.5 |
| 非流动资产: | | | | |
| 长期应收款 | 18,802,438.4 | 23,142,453.48 | 24,520,242.62 | 24,466,360.17 |
| 长期股权投资 | 5,197,561.41 | 3,223,742.83 | 3,282,839.58 | 3,322,480.87 |
| 其他权益工具投资 | 20,407,258 | 20,407,258 | 23,393,686 | 23,393,686 |
| 投资性房地产 | 553,791.73 | 558,236.44 | 345,862.89 | 567,125.84 |
| 固定资产 | 793,654,412.52 | 793,987,366.26 | 821,558,490.7 | 839,665,991.29 |
| 在建工程 | 883,445.4 | 532,850.11 | 564,310.33 | 1,640,045.17 |
| 使用权资产 | 48,427,316.08 | 50,523,013.13 | 53,386,102.46 | 52,806,026.37 |
| 无形资产 | 345,706,238.67 | 355,934,095.36 | 376,230,251.91 | 380,726,082.6 |
| 开发支出 | 155,588,923.33 | 151,397,440.26 | 180,372,583 | 176,225,345.04 |
| 商誉 | 602,530,821.95 | 608,902,942.94 | 677,189,089.12 | 678,593,752.54 |
| 长期待摊费用 | 38,389,299.67 | 38,754,293.43 | 39,975,689.28 | 47,912,848.42 |
| 递延所得税资产 | 172,913,585.53 | 172,597,517.77 | 239,082,216.17 | 236,024,999.37 |
| 其他非流动资产 | 6,556,863.27 | 14,316,061.39 | 13,783,438 | 12,978,066.83 |
| 非流动资产合计 | 2,209,611,955.96 | 2,234,277,271.4 | 2,453,684,802.06 | 2,478,322,810.51 |
| 资产总计 | 4,546,728,045.45 | 4,641,435,221.85 | 5,170,207,077.81 | 5,217,650,489.01 |
| 流动负债: | | | | |
| 短期借款 | 346,626,464.13 | 336,762,887.15 | 309,419,850.98 | 232,011,785.8 |
| 应付票据及应付账款 | 314,640,893.5 | 319,396,949.77 | 305,922,438.79 | 293,649,294.1 |
| 其中：应付票据 | 12,791,665.03 | 5,153,531.88 | 34,559,973.83 | 19,289,606.06 |
| 应付账款 | 301,849,228.47 | 314,243,417.89 | 271,362,464.96 | 274,359,688.04 |
| 合同负债 | 141,675,871.7 | 135,770,020.58 | 118,368,577.95 | 113,410,746.66 |
| 应付职工薪酬 | 54,753,909.94 | 92,338,251.62 | 70,061,041.12 | 64,006,145.93 |
| 应交税费 | 10,354,585.4 | 11,970,642.09 | 10,518,513.96 | 9,814,927.07 |
| 其他应付款合计 | 125,568,339.32 | 130,242,071.8 | 125,016,687.06 | 124,287,548.84 |
| 其中:应付利息 | 3,038,897.17 | 1,931,804.57 | 799,888.57 | 3,128,205.28 |
| 应付股利 | 38,000,000 | 38,000,000 | 38,000,000 | 38,000,000 |
| 一年内到期的非流动负债 | 282,209,624.86 | 281,362,650.95 | 280,718,681.75 | 60,778,296.77 |
| 其他流动负债 | 46,064,228.18 | 44,796,981.08 | 10,474,980.76 | 19,651,979.53 |
| 流动负债合计 | 1,321,893,917.03 | 1,352,640,455.04 | 1,230,500,772.37 | 917,610,724.7 |
| 非流动负债: | | | | |
| 长期借款 | 58,361,155.95 | 58,467,003.45 | 68,176,757.42 | 78,038,294.26 |
| 应付债券 | - | - | - | 218,362,030.6 |
| 租赁负债 | 18,209,435.15 | 22,114,182.74 | 25,640,756.86 | 25,743,967.77 |
| 预计负债 | 61,057,322.76 | 60,806,593.7 | 59,545,620.5 | 74,884,867.87 |
| 递延收益 | 27,810,367.31 | 28,850,310.81 | 30,130,749.78 | 31,905,390.71 |
| 递延所得税负债 | 8,758,512.21 | 9,004,205.28 | 9,455,992.99 | 9,970,607.03 |
| 非流动负债合计 | 174,196,793.38 | 179,242,295.98 | 192,949,877.55 | 438,905,158.24 |
| 负债合计 | 1,496,090,710.41 | 1,531,882,751.02 | 1,423,450,649.92 | 1,356,515,882.94 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 514,350,669 | 514,349,558 | 514,348,244 | 514,318,459 |
| 其他权益工具 | 43,381,664.2 | 43,386,107.98 | 43,391,363.23 | 43,511,538.37 |
| 资本公积 | 229,501,204.1 | 228,945,890.78 | 228,915,171.79 | 228,224,791.45 |
| 减:库存股 | 101,017,583.6 | 101,017,583.6 | 101,017,583.6 | 101,017,583.6 |
| 其他综合收益 | 1,292,317.95 | 13,327,989.78 | 19,570,914.46 | 23,098,912.4 |
| 盈余公积 | 228,578,647.53 | 228,578,647.53 | 228,578,647.53 | 228,578,647.53 |
| 未分配利润 | 1,661,892,957.77 | 1,710,344,230.54 | 2,209,952,438.43 | 2,309,032,540.67 |
| 归属于母公司股东权益合计 | 2,577,979,876.95 | 2,637,914,841.01 | 3,143,739,195.84 | 3,245,747,305.82 |
| 少数股东权益 | 472,657,458.09 | 471,637,629.82 | 603,017,232.05 | 615,387,300.25 |
| 股东权益合计 | 3,050,637,335.04 | 3,109,552,470.83 | 3,746,756,427.89 | 3,861,134,606.07 |
| 负债和股东权益合计 | 4,546,728,045.45 | 4,641,435,221.85 | 5,170,207,077.81 | 5,217,650,489.01 |
| 公告日期 | 2026-04-28 | 2026-04-17 | 2025-10-30 | 2025-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |